<DOC>
	<DOCNO>NCT01821547</DOCNO>
	<brief_summary>Hepatitis B vaccine safe effective vaccine use widely throughout world . Because useful vaccine develop new method study immune response . Measuring immune response vaccine help u understand work whether likely protect individual infection . For vaccine measure immune system 's production antibody vaccine give . The investigator want develop new method give far detailed picture antibody response vaccines previously possible . These method investigate genetic instruction use antibody produce cell make antibody . These method potential give new insight way vaccine work , could apply study vaccine vaccine schedule future .</brief_summary>
	<brief_title>New Methods Measure Immune Response Hepatitis B Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All participant part 1 2 must meet following condition order enrol : Participant willing able give inform consent participation study Healthy Male Female , age 18 60 year No allergy vaccine excipients Participants enrol Part 1 must also meet following condition : Participant previously receive primary immunisation course HepB vaccine ( 3 primary dos ) . The 4th booster dose recommend 12 month requirement . There variety possible recommended schedule , may use long final vaccine ( booster vaccine ) give least 12 month prior participant enrol study . Participant willing allow General Practitioner notify , appropriate , participation study Participants enrol Part 2 must also meet following condition Participant receive HBvaxProÂ® ( usual vaccine give within Occupational Health Department ) . The participant may enter either study ANY follow apply : Have know suspected impairment alteration immune function , result , example : Congenital acquire immunodeficiency ( include IgA deficiency ) Human Immunodeficiency Virus infection symptoms/signs suggestive HIVassociated condition Autoimmune disease Receipt immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 12 month longterm systemic corticosteroid therapy . Chronic illness could interfere immunological function donation require volume blood ( e.g . cardiac renal disease , diabetes , autoimmune disorder ) . Receipt HepB booster vaccine within past 12 month . Prior history anaphylactic reaction previous dose Hepatitis B contain vaccine know hypersensitivity vaccine component ; Receipt blood , blood product , plasma derivative within past 3 month . Total blood donation great 50 ml within past 3 month . Thrombocytopenia bleed disorder . Pregnancy confirm positive pregnancy test , currently breastfeed . Receipt live vaccine within 4 week prior vaccination kill vaccine within 7 day prior vaccination . Plan receive vaccine study vaccine within 4 week follow vaccination . Enrolled another study , , opinion investigator , could compromise integrity either study conduct . A member staff delegation log According TOPS database , recently take part significant number study , , opinion investigator , warrant exclusion study . Participant known nonresponder HepB vaccine Have condition , , opinion investigator , might interfere evaluation study objective . Unable understand English , require study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>